NM_000722.4:c.2126G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000722.4(CACNA2D1):​c.2126G>A​(p.Ser709Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00332 in 1,588,146 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 13 hom. )

Consequence

CACNA2D1
NM_000722.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.56

Publications

20 publications found
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
  • short QT syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • developmental and epileptic encephalopathy 110
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008761466).
BP6
Variant 7-81971792-C-T is Benign according to our data. Variant chr7-81971792-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 13 AD,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000722.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
NM_000722.4
MANE Select
c.2126G>Ap.Ser709Asn
missense
Exon 26 of 39NP_000713.2
CACNA2D1
NM_001366867.1
c.2162G>Ap.Ser721Asn
missense
Exon 26 of 39NP_001353796.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D1
ENST00000356860.8
TSL:1 MANE Select
c.2126G>Ap.Ser709Asn
missense
Exon 26 of 39ENSP00000349320.3
CACNA2D1
ENST00000443883.2
TSL:5
c.2162G>Ap.Ser721Asn
missense
Exon 26 of 39ENSP00000409374.2
CACNA2D1
ENST00000705962.1
c.2006G>Ap.Ser669Asn
missense
Exon 25 of 38ENSP00000516190.1

Frequencies

GnomAD3 genomes
AF:
0.00227
AC:
344
AN:
151696
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000989
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00384
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00254
AC:
636
AN:
250464
AF XY:
0.00269
show subpopulations
Gnomad AFR exome
AF:
0.000495
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00379
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00342
Gnomad NFE exome
AF:
0.00391
Gnomad OTH exome
AF:
0.00361
GnomAD4 exome
AF:
0.00343
AC:
4926
AN:
1436332
Hom.:
13
Cov.:
27
AF XY:
0.00348
AC XY:
2490
AN XY:
716062
show subpopulations
African (AFR)
AF:
0.000577
AC:
19
AN:
32918
American (AMR)
AF:
0.00121
AC:
54
AN:
44614
Ashkenazi Jewish (ASJ)
AF:
0.00383
AC:
99
AN:
25846
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39396
South Asian (SAS)
AF:
0.000550
AC:
47
AN:
85486
European-Finnish (FIN)
AF:
0.00337
AC:
180
AN:
53358
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5700
European-Non Finnish (NFE)
AF:
0.00398
AC:
4334
AN:
1089540
Other (OTH)
AF:
0.00323
AC:
192
AN:
59474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
211
422
634
845
1056
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00227
AC:
344
AN:
151814
Hom.:
0
Cov.:
32
AF XY:
0.00202
AC XY:
150
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.000579
AC:
24
AN:
41486
American (AMR)
AF:
0.000987
AC:
15
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3466
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5172
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00384
AC:
260
AN:
67760
Other (OTH)
AF:
0.00237
AC:
5
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00365
Hom.:
1
Bravo
AF:
0.00238
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.00268
AC:
325
Asia WGS
AF:
0.000289
AC:
1
AN:
3468

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA2D1: PP2, BS1, BS2

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 03, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23874304, 30027834, 27711072, 25527503, 23414114, 20817017, 26498160, 22840528, 26707467, 30821013)

not specified Benign:2
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Brugada syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Nov 10, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

CACNA2D1-related disorder Benign:1
Mar 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.041
T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0088
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PhyloP100
2.6
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.86
N
REVEL
Benign
0.10
Sift
Benign
0.26
T
Sift4G
Benign
1.0
T
Polyphen
0.0030
B
Vest4
0.15
MVP
0.11
MPC
0.43
ClinPred
0.011
T
GERP RS
5.2
Varity_R
0.094
gMVP
0.58
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78086631; hg19: chr7-81601108; COSMIC: COSV62391757; COSMIC: COSV62391757; API